October 25, 2021
Dr. Davendra Sohal and Dr. Jordan Kharofa spoke with Angenette Levy of 55KRC on her Simply Medicine program about the risk factors of liver cancer and a new clinical trial scheduled to begin at the UC Cancer Center in January 2022.
September 20, 2021
Amanda Jackson, MD, associate professor and director of gynecologic oncology, spoke with Angenette Levy of 55KRC on the Simply Medicine podcast to discuss Ovarian Cancer Awareness Month.
March 17, 2022
WVXU featured the University of Cincinnati's Dr. Tahir Latif in a news story about how immunocompromised people are navigating life with most mask guidelines being lifted.
January 23, 2024
The Cancer Letter highlighted the University of Cincinnati Cancer Center’s Maria Czyzyk-Krzeska's new NIH-funded research that will investigate how copper contributes to the advancement and recurrence of clear cell renal cell carcinoma.
October 13, 2021
WCPO tells the story of Sherry Hughes' breast cancer journey and treatment at the UC Cancer Center.
October 22, 2021
The University of Cincinnati's Dr. Bryan Hambley was featured in a Cincinnati Enquirer article highlighting how Colin Powell's death has highlighted the importance of vaccinations for multiple myeloma patients who are immunocompromised.
November 29, 2021
A Medscape article features Dr. Rekha Chaudhary's comments on a new triplet therapy for metastatic melanoma patients.
February 9, 2023
University of Cincinnati Cancer Center clinical oncology dietitian Stacy Shawhan joined 55KRC's Simply Medicine to discuss the myth that sugar feeds cancer cells and helps them grow.
March 24, 2022
The University of Cincinnati is enrolling patients for a new clinical trial testing a two-pronged immunotherapy approach to treat glioblastomas, deadly brain tumors.
February 2, 2022
The University of Cincinnati's Chad Zender is leading a clinical trial studying if using a combination of Cesium-131 radioactive seeds and immunotherapy can be more effective and provide better quality of life than current treatments for patients with recurrent head and neck cancer.